A study published in Nature Communications sheds light on dopamine transporter (DAT) function, which regulates brain reward centre communication. The researchers discovered DAT depends on potassium, not just sodium, rewriting textbooks on its mechanism.
A new circuit model provides an explanation for how deep brain stimulation (DBS) relieves Parkinson's disease motor symptoms by interrupting a vicious cycle between the subthalamic nucleus and the striatum. The model suggests that DBS restores a balance with other rhythm frequencies, enabling better movement control.
Research found that voluntary wheel running increased dopamine signaling in motor areas of mice. This increase remained even after exercise ended. The study suggests BDNF may catalyze increased dopamine signaling.
A new study reveals that running increases dopamine release and brain-derived neurotrophic factor (BDNF) levels, leading to improved learning, memory, and motor skills. The findings provide insight into the long-term effects of exercise on the brain and may lead to new treatments for Parkinson's disease.
Researchers have developed a process to convert non-neuronal cells into functioning neurons that can take up residence in the brain and restore capacities undermined by Parkinson's destruction of dopaminergic cells. In a proof-of-concept study, one group of experimentally engineered cells performs optimally in terms of survival, growth...
Researchers at NC State University have created a stem cell-derived model that sheds light on the effect of dopamine on gene activity in neurons, revealing gene desensitization in human cells. The study provides a blueprint for future research into the relationship between dopamine and addiction.
A new UCI study identifies a single brain pathway centered around dopamine cells responsible for cocaine withdrawal-induced anxiety and relapse-related behavior. The findings offer a potential target for therapeutic interventions to prevent relapse among drug users.
Research suggests dopamine is involved in emotion recognition, particularly in low-dose individuals. Dopamine levels influence emotional perception, with lower levels improving emotional recognition while higher levels impairing it. This finding has implications for understanding social cognition impairments in neurological disorders.
Researchers at Clemson University and SSSIHL discovered a novel way to combine curcumin and gold nanoparticles to create an electrode that efficiently converts ethanol into electricity. The discovery brings replacing hydrogen as a fuel cell feedstock one step closer, with potential applications in sensors and supercapacitors.
A team at Harvard Medical School identified a mechanism that triggers local dopamine release in the brain when acetylcholine binds to axons, not previously known to initiate firing. This finding reveals more about the interaction between acetylcholine and dopamine systems, suggesting a new strategy for treating diseases like Parkinson's.
A wireless, biodegradable sensor implanted in mice detected dopamine levels and other brain properties, offering potential for real-time monitoring of neural-related conditions. The device is designed to be biodegradable, eliminating the need for future surgeries.
Scientists have created electrodes from recycled coffee grounds that can detect trace levels of biomolecules in vitro, offering a more sensitive surface for neurochemistry detection. The researchers hope to boost their neurochemical detection abilities by fabricating entire electrodes with carbon from coffee grounds.
Researchers found that a temporary increase in dopamine levels in the basolateral amygdala initiates transitions from non-rapid eye movement (NREM) to rapid eye movement (REM) sleep. This discovery may have important implications for understanding changes in sleep state and treating conditions like cataplexy and narcolepsy.
Researchers found that disruption of normal neuronal functions affects metabolic activity, potentially contributing to drug-seeking behaviors. The study suggests that alterations in dopamine signaling may reprogram the circadian liver metabolome, leading to substance use disorders.
A new study from the University of Copenhagen has made significant breakthroughs in treating Parkinson's disease by targeting specific neurons in the brainstem. By stimulating excitatory neurons in the caudal area of the pedunculopontine nucleus, researchers were able to restore normal walking function in mice with Parkinson's symptoms.
Researchers at UC San Diego's Kavli Institute for Brain and Mind discovered that fruit flies possess more sophisticated cognitive abilities than previously known. Using virtual reality and real-time brain imaging, they found attention, working memory, and conscious awareness-like capabilities in flies.
A new study on nematode worms reveals that physical contact can help prevent neuromuscular decline in simulated microgravity. Researchers found that administering dopamine restored normal movement and body length in space-grown worms.
Researchers identified three KCTD proteins that modulate neurotransmitter activity, enabling fine-tuned movement. Their elimination enhances cAMP production and sensitivity to dopamine in neurons.
A study by the Netherlands Institute for Neuroscience has identified a new neural mechanism of habit formation, showing that striatal dopamine signals are region-specific and temporally stable across action-sequence habit formation. This finding challenges traditional theories on dopamine signaling in habit development.
A recent study found that people with Parkinson's Disease who consume more flavonoids have a lower mortality risk than those who don't. The researchers discovered that higher flavonoid intake is associated with improved survival rates in both men and women, particularly when it comes to anthocyanin-rich foods like berries and red wine.
A pilot study by Kessler Foundation found that methylphenidate improved 'state' mental fatigue in individuals with multiple sclerosis, but had no effect on 'trait' fatigue. The study suggests an important role for dopamine in MS-related mental fatigue.
A new study has identified a promising drug candidate to minimize uncontrolled muscle movements associated with Parkinson’s disease. PD13R reduced dyskinesia by more than 85% in animal studies, also improving sleep quality compared to other treatments.
Researchers found that dopamine stimulates female songbirds' preference for certain songs, affecting mating choice and memory. By manipulating dopamine levels, the team demonstrated lasting changes in song preferences, advancing our understanding of auditory perception.
A research team has identified a subset of cerebellar neurons that signal satiation after eating, leading to reduced food intake in mice. The findings suggest a novel target for therapies that could curb overeating and obesity.
The American Academy of Neurology has issued a guideline recommending treatment options for early Parkinson's disease, including levodopa as the best first treatment. The guideline also highlights potential side effects and risks associated with medications, such as dyskinesia and impulse-control disorders.
A study published in Translational Psychiatry found that patients with high expectations of SSRI treatment showed a four times higher improvement rate compared to those with low expectations. The effect was attributed to the influence of dopamine on the brain's reward pathways.
Researchers have identified significant neurological effects of social isolation on the brain, including altered neural circuits and increased risk for disease. Social isolation can cause permanent changes in behavior and lead to health issues like anxiety and depression.
A new study in rodents suggests that repeated stress during infancy can lead to lasting behavioral issues due to increased dopamine levels in the brain. The research team found that stressful conditions caused pups to spend less time near their mothers and peers.
A new study reveals that pain activates a specific region of the brain, which reduces dopamine activity and leads to decreased motivation. Artificially restoring dopamine neurons reverses this effect, suggesting potential treatments for pain-related emotional changes.
Researchers have identified a new pathway for opioid-induced reward in the brain, paving the way for creating safer opioids. By altering the opioid peptide receptor MOPR, pharmaceutical companies can potentially create drugs that bypass the brain's reward system.
Researchers found that a balance between dopamine D2 receptors and RGS is crucial for normal long-term memory formation. An imbalance in these molecules is thought to contribute to the development of schizophrenia and dystonia.
Researchers at The Graduate Center, CUNY, found that increased signaling of the sonic hedgehog protein can inhibit LID in animal models of Parkinson's disease. This could lead to a potential therapeutic solution for most Parkinson's patients.
Research reveals that dopamine levels increase with stressful stimuli, rewriting the 'pleasure molecule' narrative, and suggesting new treatment approaches for psychiatric diseases and addiction. The discovery has significant implications for understanding dopamine's role in behavior and developing evidence-based treatments.
Researchers have discovered a new pathway in the brain that plays a key role in rewards and reinforcement. GABA neurons from the ventral tegmental area project to the nucleus accumbens shell, promoting reward processing. This finding offers new avenues for understanding psychiatric diseases such as depression and addiction.
A study found that transcranial stimulation can increase the benefits of aerobic exercise and improve gait in Parkinson's patients. The treatment uses a weak current delivered by electrodes placed over specific brain regions, activating the pre-frontal cortex.
A study on red junglefowl chicks found that early experiences can affect impulsivity, contradicting initial expectations. The researchers also discovered a link between gene expression and impulsivity, suggesting that genetic factors contribute to individual differences in impulsive behavior.
Researchers at UC San Diego found that mice can manipulate unpredictable dopamine pulses, which occur approximately once per minute, and learn to anticipate and act upon them. This new understanding opens a dimension in the study of dopamine and brain dynamics.
A new study suggests that gene therapy delivered into the brain may be safe and effective in treating AADC deficiency. The therapy resulted in clinical improvement of symptoms, including reduced oculogyric crises, improved movement and motor function, and better sleep patterns.
A case report highlights the importance of recognizing remdesivir-induced hemodynamically unstable sinus bradycardia in COVID-19 patients. The patient experienced significant bradycardia after starting treatment with remdesivir, but resolved after stabilization with dopamine infusion.
A new study by Norwegian University of Science and Technology researchers found that dopamine levels are linked to passion and goal achievement in men, which may explain the higher prevalence of autism diagnoses in males. The study also found no significant gender difference in passion or grit among women.
Scientists create synthetic melanin-like nanoparticles to overcome limitations of current dopamine delivery methods, achieving efficient and controlled release in the brain. The proposed method demonstrates promising results in reversing Parkinson's symptoms with high biocompatibility and non-toxicity.
Researchers have developed a novel nitrogen-doped dual-emission carbon dot as an effective fluorescent probe for ratiometric detection of dopamine. The new probe simplifies the detection process, reducing the need for complex nanomaterial combinations.
A rare mutation causes Parkinson's disease-like symptoms by disrupting dopamine transport, suggesting treatments targeting the transporters could alleviate symptoms. A malaria drug helps alleviate movement problems in genetically modified fruit flies with the mutation.
A NYITCOM researcher has secured a $1.6 million NIH grant to study the role of brain cells called astrocytes in regulating dopamine signaling. The study aims to identify new therapeutic treatments for clinical depression, which affects over 260 million people worldwide.
Researchers discovered that a protein called VGLUT plays a key role in regulating sex differences in brain vulnerability to age-related dopamine neuron loss. Higher levels of VGLUT were found in female neurons, correlating with greater resilience to neurodegeneration and mobility deficiencies.
Researchers from Osaka University discovered that subconscious viewing of one's own face can activate the dopamine reward pathway in the brain. This finding provides new insights into how the brain processes self-facial recognition and suggests that the dopamine reward pathway plays a key role in this process.
Research suggests that tolerance, cooperation, and reduced aggression in domesticated birds are linked to increased language complexity in humans. The study analyzed genomic, neurobiological differences between domesticated Bengalese finch and its wild relative, finding altered stress hormone balance and brain connectivity patterns.
Researchers at NYU Grossman School of Medicine discovered that individual nerve cells control the release of dopamine, a key player in motivation and movement. The finding challenges traditional views on dopamine regulation and provides new insights into Parkinson's disease.
A new study found that increased dopamine in the brain's striatum triggers auditory hallucination-like experiences in mice, shedding light on a possible causal role for dopamine-dependent neurological circuits in psychosis. This breakthrough could inform novel targeted treatments for schizophrenia and other psychotic disorders.
A new study in mice and people offers a promising entry point to developing new therapies for schizophrenia. Researchers found that hallucination-like events were more common among individuals who experienced spontaneous hallucinations, suggesting a link between brain circuits underlying both human and mouse minds.
A new study published in Frontiers in Synaptic Neuroscience reveals that neurons in a brain area associated with depression connect to an anti-reward system during cocaine withdrawal. This reorganization of brain circuits may drive negative behavior and depressive symptoms.
A new study published in Neuron shows that dopamine neurons play a key role in regulating pain responses in male and female mice, with females responding by focusing attention elsewhere when in pain. The research provides insights into the neural pathways involved in sex differences in pain sensitivity.
A study published in Neuron reveals that the brain learns from subconscious visual stimuli through the activation of dopamine-producing cells. The discovery has significant implications for developing targeted therapies for conditions like Parkinson's disease and improving brain plasticity in situations such as trauma or ageing.
Researchers at Osaka City University discover sesaminol protects against neuronal damage and increases dopamine levels in Parkinson's disease models. The study suggests sesaminol may be the first-ever medicine for Parkinson's disease, potentially derived from industrial waste.
Researchers at Ohio State University used graph theory to model homeostasis in the human body, predicting changes in dopamine levels and identifying properties of graphs that can help prevent system breakdowns. This approach could lead to targeted medical care for people who need it.
Grafting neurons from monkeys' own cells into their brains relieved debilitating movement and depression symptoms associated with Parkinson's disease. The autologous transplants showed significant improvements within six months, with dopamine levels doubling and tripled within a year.
A team at NYU Tandon School of Engineering developed planar micro-sensors using nano-graphitic carbon, increasing sensitivity and spatial resolution for brain studies. The sensors' performance can be adjusted by engineering material structure, offering new prospects for future brain studies.
Researchers at McMaster University have discovered a dopamine receptor pathway that becomes abnormally activated in acute myeloid leukemia (AML) cancer stem cells. This led to the clinical investigation of thioridazine as a new therapy for adult AML patients, revealing encouraging results.
Dopamine plays a key role in regulating blood glucose levels, and its blockade by antipsychotic medications can lead to uncontrolled glucose production and obesity. The study reveals that pancreatic alpha cells produce dopamine, which acts on both insulin-producing beta cells and other receptors.
A study by Scripps Research has discovered a memory gating system employing dopamine to direct transient forgetting, a temporary lapse of memory that spontaneously returns. The mechanism was found to be separate from long-term memory recall.